Expression of the SCUBE3 Epidermal Growth Factor-Related Gene During Early Embryonic Development in the Mouse

    December 2006 in “ Gene Expression Patterns
    Kim E. Haworth, Francis W. Smith, Maria Zoupa, Maisa Seppala, Paul T. Sharpe, Martyn T. Cobourne
    Image of study
    TLDR Scube3 gene affects mouse embryo growth in multiple areas, but needs more research.
    The Scube3 gene is expressed in various regions during early embryonic development in mice, including the neural tube, branchial arches, developing hair follicles, and developing kidney. It may play a role in regulating cell growth and differentiation, particularly in highly vascularized tissues. Its exact function is not yet fully understood and requires further research. The study was funded by the Wellcome Trust, European Orthodontic Society, and European Union.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 72 results

      community How all hormones affect our hair follicles. Not just DHT. Take a look at this paper. Prolactin, melatonin, cortisol, progesterone, testosterone and more

      in Research/Science  126 upvotes 2 years ago
      The conversation discusses various factors affecting hair loss, not just DHT, and mentions treatments like Minoxidil, finasteride, and melatonin. Some users report personal experiences with these treatments and hormone tests, while others speculate on the role of hormones like prolactin and cortisol in hair loss.

      community Why nobody uses 0.25% (2.5mg/ml)?

      in Treatment  65 upvotes 10 months ago
      The conversation is about the effectiveness of 0.25% topical finasteride compared to other concentrations and forms. Users discuss its potential for better scalp DHT reduction and fewer side effects, with some preferring topical over oral treatments.

      community SCUBE3 Biannual Injections and Microneedling

      in Technology  12 upvotes 7 months ago
      The conversation discusses biannual SCUBE3 injections and microneedling as treatments for hair loss. Specific treatments mentioned include Minoxidil, Finasteride, and RU58841.

      community Expectations control for SCUBE3

      in Research/Science  22 upvotes 8 months ago
      SCUBE3, a protein linked to hair growth in moles, was discovered over 25 years ago and is being developed by Amplifica for potential hair loss treatment. Concerns exist about SCUBE3's association with cancer, as it is a protein that promotes cell growth, which could potentially trigger cancer development if used for hair growth therapy.

      community Prediction: Scube3 is never coming out

      in Research/Science  6 upvotes 8 months ago
      Scube3, a potential hair loss treatment, is unlikely to be released because it was given to a startup company, Amplifica, which may go bankrupt and fail to bring the treatment to market. Amplifica is prioritizing other treatments over Scube3, which could lead to financial loss and the end of Scube3's development.

    Related Research

    1 / 1 results